Skip to main content
Premium Trial:

Request an Annual Quote

Boston Hospitals Wins Pediatric Cardiac Genomics Funding

NEW YORK (GenomeWeb News) – Scientists at Brigham and Women's Hospital and Children's Hospital Boston will use a $4.2 million grant from the National Heart, Lung, and Blood Institute to identify genetic and epigenetic causes of congenital heart disease.

Funded through the NHLBI's Pediatric Cardiac Genomics Consortium, the researchers will relate genetic variants found in patients with congenital heart disease to clinical outcomes.

Because this effort is aimed at discovering novel genes, the researchers will require a collaborative group like the PCGC that offers shared samples, data, and technology, the partners said.

"Everybody recognizes that no one center alone can do this research," Jane Newburger, associate chief for academic affairs in the department of cardiology at Children's Hospital, and professor of Pediatrics at Harvard Medical School, said in a statement.

"The collaborative effort is the only way we have a chance of making big discoveries in a short period of time," explained Amy Roberts, who is assistant professor in pediatrics at Harvard Medical School.

The PCGC is part of NHLBI's Bench to Bassinet initiative, and it aims to identify preventive strategies, targets for treatment, and better diagnostic and prognostic information.

"Too many young lives are lost each year due to congenital heart defects," added Susan Shurin, acting director at NHLBI. "To help give these children a chance at a healthier life, the Bench to Bassinet program will delve into how the cardiovascular system develops and help translate the best research findings into clinical practice."

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.